Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

4-(DIPHENYLMETHOXY)-1-[3-(1H-TETRAZOL-5-YL)PROPYL]-PIPERIDINE

4-(DIPHENYLMETHOXY)-1-[3-(1H-TETRAZOL-5-YL)PROPYL]-PIPERIDINE Structure
  • ₹11506.98 - ₹46374.3
  • Product name: 4-(DIPHENYLMETHOXY)-1-[3-(1H-TETRAZOL-5-YL)PROPYL]-PIPERIDINE
  • CAS: 162641-16-9
  • MF: C22H27N5O
  • MW: 377.48
  • EINECS:
  • MDL Number:MFCD00936179
  • Synonyms:HQL-79;4-(Diphenylmethoxy)-1-(3-2H-tetrazol-5-yl)propyl]-piperidine;HQL-97;4-(DIPHENYLMETHOXY)-1-[3-(1H-TETRAZOL-5-YL)PROPYL]-PIPERIDINE;CS-620;HQL 79;HQL79;Piperidine, 4-(diphenylmethoxy)-1-[3-(2H-tetrazol-5-yl)propyl]-;1-(3-(1H-Tetrazol-5-yl)propyl)-4-(benzhydryloxy)piperidine
2 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 5MG
  • 25MG
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML0857
  • Product descriptionHQL 79 ≥98% (HPLC)
  • Packaging5MG
  • Price₹11506.98
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML0857
  • Product descriptionHQL 79 ≥98% (HPLC)
  • Packaging25MG
  • Price₹46374.3
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) SML0857 HQL 79 ≥98% (HPLC) 5MG ₹11506.98 2022-06-14 Buy
Sigma-Aldrich(India) SML0857 HQL 79 ≥98% (HPLC) 25MG ₹46374.3 2022-06-14 Buy

Properties

Boiling point :553.6±60.0 °C(Predicted)
Density :1.21
storage temp. :Store at RT
solubility :DMSO: soluble2mg/mL, clear (warmed)
form :powder
pka :4.85±0.10(Predicted)
color :white to beige

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

HQL-79 is a selective inhibitor of hematopoietic prostaglandin D (PGD) synthase. Structurally, it is a synthetic tetrazole compound originally prepared as a possible antihistamine. Subsequent evaluation in models of allergy and asthma demonstrates the HQL-79 is orally available, and inhibits the synthesis of PGD2 . HQL-79 is thus a likely lead compound for the preparation of potent, selective hematopoietic PGD synthase inhibitors.

Related product price